for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

McKesson Corporation

MCK.N

Latest Trade

202.59USD

Change

1.79(+0.89%)

Volume

149,956

Today's Range

201.76

 - 

203.60

52 Week Range

141.33

 - 

210.00

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Ontada Signs Strategic Agreement With Merck To Facilitate Development Of Data-Driven Insights To Impact Quality Of Cancer Care

Aug 26 (Reuters) - Ontada::ONTADA SIGNS STRATEGIC AGREEMENT WITH MERCK TO FACILITATE DEVELOPMENT OF DATA-DRIVEN INSIGHTS TO IMPACT QUALITY OF CANCER CARE.ONTADA - CO, MCKESSON'S ONCOLOGY AND INSIGHTS BUSINESS, TODAY ANNOUNCED A STRATEGIC AGREEMENT WITH MERCK.ONTADA - AS PART OF AGREEMENT, MERCK, CO CAN COLLABORATE ON RWD STUDIES, ADVANCED METHODS DEVELOPMENT, AND ASSESSMENT OF EFFICIENCY IN CANCER CARE.

Mckesson Says In June, U.S. DOJ Served Civil Investigative Demand On Co Seeking Documents Related To Distribution Arrangements For Ophthalmology Products

Aug 5 (Reuters) - Mckesson Corp <MCK.N>::MCKESSON - IN JUNE, U.S. DOJ SERVED CIVIL INVESTIGATIVE DEMAND ON CO SEEKING DOCUMENTS RELATED TO DISTRIBUTION ARRANGEMENTS FOR OPHTHALMOLOGY PRODUCTS.

McKesson Reports Fiscal 2022 First-Quarter Results

Aug 4 (Reuters) - Mckesson Corp <MCK.N>::MCKESSON REPORTS FISCAL 2022 FIRST-QUARTER RESULTS.QTRLY TOTAL REVENUES OF $62.7 BILLION INCREASED 13%.QTRLY ADJUSTED EARNINGS PER DILUTED SHARE OF $5.56 INCREASED 101%.QTRLY EARNINGS PER DILUTED SHARE FROM CONTINUING OPERATIONS OF $3.09.BOARD OF DIRECTORS INCREASED THE QUARTERLY DIVIDEND BY 12% TO $0.47 PER SHARE.Q1 EARNINGS PER SHARE VIEW $4.15, REVENUE VIEW $60.09 BILLION -- REFINITIV IBES DATA.MCKESSON - FISCAL 2022 GUIDANCE ASSUMES $0.80 TO $1.00 OF ADJUSTED EPS RELATED TO U.S. GOVERNMENT'S COVID-19 VACCINE DISTRIBUTION AND KITTING PROGRAMS.MCKESSON - CLAIMS, LITIGATION CHARGES, NET FOR QUARTER-ENDED JUNE 30, 2021 INCLUDES A PRE-TAX CHARGE OF $27 MILLION AND A PRE-TAX CHARGE OF $47 MILLION.MCKESSON - IN QUARTER, PRE-TAX CHARGE OF $27 MILLION RELATED TO AGREEMENT TO SETTLE OPIOID-RELATED CLAIMS WITH STATE OF NEW YORK, PARTICIPATING SUBDIVISIONS.MCKESSON -IN QUARTER, $47 MILLION PRE-TAX CHARGE RELATED TO ESTIMATED LIABILITY FOR PROPOSED AGREEMENT TO SETTLE OPIOID-RELATED CLAIMS OF PARTICIPATING STATES.

McKesson Raises Quarterly Dividend By 12% To $0.47 Per Share

July 26 (Reuters) - McKesson Corp <MCK.N>::MCKESSON RAISES QUARTERLY DIVIDEND BY 12% TO $0.47 PER SHARE.

McKesson To Sell Some European Businesses To Phoenix Group

July 7 (Reuters) - McKesson Corp <MCK.N>::TO SELL SOME EUROPEAN BUSINESSES TO PHOENIX GROUP INCLUDING BUSINESSES IN FRANCE, ITALY, IRELAND, PORTUGAL, BELGIUM, SLOVENIA.COMMITTED TO EXPLORE STRATEGIC ALTERNATIVES FOR REMAINING BUSINESSES IN UK, NORWAY, AUSTRIA, AND DENMARK.

Mckesson Reports Fiscal 2021 Fourth-Quarter And Full-Year Results

May 6 (Reuters) - Mckesson Corp <MCK.N>::MCKESSON REPORTS FISCAL 2021 FOURTH-QUARTER AND FULL-YEAR RESULTS.Q4 ADJUSTED EARNINGS PER SHARE $5.05.Q4 EARNINGS PER SHARE $4.15 FROM CONTINUING OPERATIONS.Q4 REVENUE ROSE 1 PERCENT TO $59.1 BILLION.SEES FY ADJUSTED EARNINGS PER SHARE $18.85 TO $19.45 INCLUDING ITEMS.Q4 EARNINGS PER SHARE VIEW $5.04, REVENUE VIEW $61.09 BILLION -- REFINITIV IBES DATA.FY2021 EARNINGS PER SHARE VIEW $17.23 -- REFINITIV IBES DATA.FY2022 EARNINGS PER SHARE VIEW $18.85 -- REFINITIV IBES DATA.MCKESSON - FISCAL 2022 ADJUSTED EARNINGS PER DILUTED SHARE GUIDANCE ASSUMES $0.40 TO $0.50 RELATED TO U.S. GOVERNMENT COVID-19 VACCINE DISTRIBUTION.SEES FISCAL 2022 REVENUES 3% TO 6% GROWTH.

Mckesson Corp Says On March 31, Co Amended Credit Agreement, Dated As Of September 25, 2019

April 2 (Reuters) - Mckesson Corp <MCK.N>::MCKESSON CORP SAYS ON MARCH 31, CO ENTERED INTO AMENDMENT NO. 2, TO CREDIT AGREEMENT, DATED AS OF SEPTEMBER 25, 2019 - SEC FILING.MCKESSON - AMENDMENT REVISES SECTION 7.04 OF 2019 CREDIT FACILITY TO REQUIRE CO TO MAINTAIN LEVERAGE RATIO OF TOTAL DEBT TO CONSOLIDATED EBITDA OF AT LEAST 4:1.

Mckesson Says Has Distributed Over 25 Mln Doses Of Moderna's Covid-19 Vaccine Through Jan: Conf Call

Feb 2 (Reuters) - Mckesson Corp <MCK.N>::MCKESSON SAYS HAS DISTRIBUTED OVER 25 MILLION DOSES OF MODERNA'S COVID-19 VACCINE THROUGH JAN: CONF CALL.MCKESSON PRODUCING ENOUGH ANCILLARY KITS EACH WEEK TO SUPPORT 10 TO 15 MILLION VACCINE DOSES: CONF CALL.

Mckesson Corp Reports Q3 Results

Feb 2 (Reuters) - Mckesson Corp <MCK.N>::Q3 ADJUSTED EARNINGS PER SHARE $4.60.Q3 REVENUE $62.6 BILLION VERSUS REFINITIV IBES ESTIMATE OF $61.71 BILLION.Q3 EARNINGS PER SHARE ESTIMATE $4.13 -- REFINITIV IBES DATA.Q3 LOSS PER SHARE $39.03.BOARD OF DIRECTORS AUTHORIZED AN ADDITIONAL $2.0 BILLION SHARE REPURCHASE PROGRAM.INCREASED FISCAL 2021 ADJUSTED EARNINGS PER DILUTED SHARE GUIDANCE RANGE TO $16.95 TO $17.25.FISCAL 2021 ADJUSTED EARNINGS PER DILUTED SHARE GUIDANCE ASSUMES $0.25 TO $0.35 RELATED TO COVID-19 VACCINE DISTRIBUTION.COVID-19 VACCINE DISTRIBUTION HAS BEEN HIGHLY SUCCESSFUL, ACHIEVING ALL VOLUME AND TIMING REQUIREMENTS BY THE GOVERNMENT.MCKESSON-FISCAL 2021 GUIDANCE CONTINUES TO ASSUME FULL RECOVERY OF PHARMACEUTICAL PRESCRIPTION VOLUMES,PATIENT VISITS WILL NOT OCCUR THIS FISCAL YEAR.ON OPIOID-RELATED CHARGES, IN Q3 OF FISCAL 2021, MCKESSON RECORDED A GAAP-ONLY PRE-TAX CHARGE OF $8.1 BILLION.Q3 EARNINGS PER SHARE VIEW $4.13 -- REFINITIV IBES DATA.Q3 REVENUE VIEW $61.71 BILLION -- REFINITIV IBES DATA.

Mckesson Corp Files Pricing Term Sheet For $500 Mln 0.900% Notes Due 2025

Nov 30 (Reuters) - Mckesson Corp <MCK.N>::MCKESSON CORP FILES PRICING TERM SHEET FOR $500 MILLION 0.900% NOTES DUE 2025 - SEC FILING.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up